Effects of fluid therapy following aneurysmal subarachnoid haemorrhage: A prospective clinical study

British Journal of Neurosurgery

Volumn 22, Issue 2, 2008, Pages 257-268

  Tseng, M Y ^a   Hutchinson, P J ^a   Kirkpatrick, P J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Crystalloid; Haemodilution; Subarachnoid haemorrhage; Synthetic colloid; Transfusion

Indexed keywords

GELATIN SUCCINATE; HETASTARCH; INFUSION FLUID; NIMODIPINE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CLINICAL TRIAL; COLLOID; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYSTALLOID; FEMALE; FLUID THERAPY; GLASGOW COMA SCALE; HEMODILUTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; STATISTICAL ANALYSIS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOSPASM;

ADULT; AGED; BLOOD TRANSFUSION; BRAIN ISCHEMIA; COLLOIDS; FEMALE; FLUID THERAPY; HUMANS; INFUSIONS, INTRAVENOUS; ISOTONIC SOLUTIONS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 40949125241     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.1080/02688690701832100     Document Type: Article

References (34)

1. Lindsay KW, Langham J, Kirkpatrick PJ, et al. Final report of an audit carried out in 34 neurosurgical units in the UK and Ireland between 14 September 2001 to 13 September 2002. National Study of Subarachnoid Haemorrhage. London: Royal College of Surgeons of England, 2006.
2. Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid hemorrhage: British aneurysm nimodipine trial. BMJ 1989;298:636-42.
3. Pritz MB, Giannotta SL, Kindt GW, McGillicuddy JE, Prager RL. Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion. Neurosurgery 1978;3:364-8.
4. Hino A, Mizukawa N, Tenjin H, et al. Postoperative hemodynamic and metabolic changes in patients with subarachnoid hemorrhage. Stroke 1989;20:1504-10.
5. Naidech AM, Drescher J, Ault ML, et al. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery 2006;59:775-9.
6. Reasoner DK, Ryu KH, Hindman BJ, Cutkomp J, Smith T. Marked hemodilution increases neurologic injury after focal cerebral ischemia in rabbits. Anesth Analg 1996;82:61-7.
7. Treggiari MM, Walder B, Suter PM, Romand JA. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 2003;98:978-84.
8. Roberts I, Alderson P, Chinnock P, Ker K, Schierhour G. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database System Rev 2004;4:CD000567.
9. The SAFE Study Investigators. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007;357:874-84.
10. Wiedermann CJ. Complications of hydroxyethyl starch in acute ischemic stroke and other brain injuries. Pathophysiol Haemost Thromb 2003;33:225-8.
11. Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomised placebo-controlled trial. Stroke 2005;36:1627-32.
12. Tseng MY, Richards H, Czosnyka M, Pickard JD, Kirkpatrick PJ. Acute systemic erythropoietin therapy reduces cerebral vasospasm and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized, double-blind, placebo-controlled trial. J Neurosurg 2007;106:A768.
13. Drake CG. Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid haemorrhage grading scale. J Neurosurg 1988;68:985-6.
14. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid haemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1-9.
15. Aaslid R. Transcranial Doppler assessment of cerebral vasospasm. Eur J Ultrasound 2002;16:3-10.
16. Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P. Cerebral vasospasm after subarachnoid haemorrhage investigated by means of transcranial Doppler ultrasound. Acta Neurochir Suppl (Wien) 1988;42:81-4.
17. Giller CA. A bedside test for cerebral autoregulation using transcranial Doppler ultrasound. Acta Neurochir (Wien) 1991;108:7-14.
18. Smielewski P, Czosnyka M, Kirkpatrick P, Pickard JD. Evaluation of the transient hyperemic response test in head-injured patients. J Neurosurg 1997;86:773-8.
19. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975:1:480-4.
20. Dunnett CW. A multicomparison procedure for comparing several treatments with a control. J Am Stat Soc 1955;50:1096-21.
21. Dumont AS, Dumont RJ, Chow MM, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003;53:123-35.
22. Smith MJ, Le Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid haemorrhage. J Neurosurg 2004;101:1-7.
23. Veldman BAJ, Schepkens HLE, Vervoort G, Klasen I, Wetzels JFM. Low concentrations of intravenous polygelines promote low-molecular weight proteinuria. Eur J Clin Invest 2003;33:962-8.
24. Haeberle HA, Hohe B, Eltzschig HK, Unertl K, Dieterich H. Effect of synthetic colloids on major histocompatibility complex II expression. J Clin Anesth 2006;18:96-101.
25. van Rijen EA, Ward JJ, Little RA. Effects of colloidal resuscitation fluids on reticuloendothelial function and resistance to infection after hemorrhage. Clin Diagn Lab Immunol 1998;5:543-9.
26. Rittoo D, Gosling P, Simms MH, Smith SR, Vohra RK. The effects of hydroxyethyl starch compared with gelofusine on activated endothelium and the systemic inflammatory response following aortic aneurysm repair. Eur J Vasc Endovasc Surg 2005;30:520-4.
27. Freyburger G, Dubreuil M, Boisseau MR, Janvier G. Rheological properties of commonly used plasma substitutes during preoperative normovolaemic acute haemodilution. Br J Anaesth 1996;76:519-25.
28. Suempelmann R, Guenther A, Zander R. Haemoconcentration by gelatin-induced acceleration of erythrocyte sedimentation rate. Anaesthesia 2000;55:217-20.
29. De Lorenzo C, Calatzis A, Welsch U, Heindl B. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesth Analg 2006;102:1194-200.
30. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg 2006;102:998-1006.
31. Trumble ER, Muizelaar JP, Myseros JS, Choi SC, Warren BB. Coagulopathy with the use of hetastarch in the treatment of vasospasm. J Neurosurg 1995;82:44-7.
32. Belayev L, Liu Y, Zhao W, Busto R, Ginsberg MD. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke 2001;32:553-60.
33. Moreau R, Valla DC, Durand-Zaleski I, et al. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail. Liver Int 2006;26:46-54.
34. Rodriguez RM, Corwin HL, Gettinger A, et al. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 2001;16:36-41.